Neurological aspects of biological and chemical terrorism: A review for neurologists

Archives of Neurology

Volumn 60, Issue 1, 2003, Pages 21-25

  Martin, Coleman O ^a   Adams Jr , Harold P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRATE; ANTHRAX VACCINE; ANTITOXIN; ATROPINE; BOTULINUM TOXIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CYANIDE; DOXYCYCLINE; HYDROXOCOBALAMIN; ORGANOPHOSPHATE INSECTICIDE; PENICILLIN G; PRALIDOXIME CHLORIDE; SARIN; SODIUM NITRATE; SODIUM THIOSULFATE; TABUN; VANCOMYCIN;

ANTHRAX; ARMY; BACILLUS ANTHRACIS; BACTERIAL TRANSMISSION; BIOLOGICAL WARFARE; BOTULISM; CLINICAL FEATURE; COMA; CONVULSION; CRANIAL NERVE PARALYSIS; CYANIDE POISONING; DELIRIUM; DOSE RESPONSE; EARLY DIAGNOSIS; FASCICULATION; HEADACHE; HUMAN; HYPERTHERMIA; INFECTION RISK; INTOXICATION; MENINGITIS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROLOGY; NONHUMAN; ORGANOPHOSPHATE POISONING; PASSIVE IMMUNIZATION; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SKIN DECONTAMINATION; TERRORISM; VERTIGO;

EID: 0037225360     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.1.21     Document Type: Review

References (26)

1. Hall AH, Rumack BH. Clinical toxicology of cyanide. Ann Emerg Med. 1986;15:1067-1074.
2. Yen D, Tsai J, Wang LM, Kao WF, Hu SC, Deng JF. The clinical experience of acute cyanide poisoning. Am J Emerg Med. 1995;13:524-528.
3. Holland MA, Kozlowski LM. Clinical features and management of cyanide poisoning. Clin Pharm. 1986;5:737-741.
4. Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS. Goldfrank's Toxicologic Emergencies. 5th ed. Norwalk, Conn: Appleton & Lange; 1994.
5. Chin RG, Calderon Y. Acute cyanide poisoning: a case report. J Emerg Med. 2000;18:441-445.
6. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med. 2001;37:635-641.
7. Albin R. Basal ganglia neurotoxins. Neurol Clin. 2000;18:665-680.
8. Karalliedde L, Wheeler H, Maclehose R, Murray V. Possible immediate and longterm health effects following exposure to chemical warfare agents. Public Health. 2000;114:238-248.
9. Gunderson CH, Lehmann CR, Sidel FR, Jabbari B. Nerve agents: a review. Neurology. 1992;42:946-950.
10. Singh S, Chaudhry D, Bechera D, Gupta D, Jindal SK. Aggressive atropinization and continuous pralidoxime (2-PAM) infusion in patients with severe organophosphate poisoning: experience of a northwest Indian hospital. Hum Exp Toxicol. 2001;20:15-18.
11. Dunn MA, Sidell FR. Progress in medical defense against nerve agents. JAMA. 1989;262:649-652.
12. He F, Xu H, Qin F, Xu L, Huang J, He X. Intermediate myasthenia syndrome following acute organophosphates poisoning: an analysis of 21 cases. Hum Exp Toxicol. 1998;17:40-45.
13. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphate insecticides. N Engl J Med. 1987;316:761-763.
14. De Bleecker JL, De Reuck JL, Willems JL. Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg. 1992;94:93-103.
15. Arnon S, Schechter R, Inglesby TV, et al, for the Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon. JAMA. 2001;285:1059-1070.
16. Shapiro R, Hatheway C, Swerdlow D. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129:221-228.
17. Townes J, Cieslak PR, Hatheway CL, et al. An outbreak of type A botulism associated with a commercial cheese sauce. Ann Intern Med. 1996;125:558-563.
18. Hibbs RG, Webster TJ, Corwin A, et al. Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin Infect Dis. 1996;23:337-340.
19. Mayer SA. Intensive care of the myasthenic patient. Neurology. 1997;48(suppl 5):S70-S75.
20. Inglesby TV, Henderson DA, Bartlett JG, et al, for the Working Group on Civilian Biodefense. Anthrax as a biological weapon. JAMA. 1999;281:1735-1745.
21. Berthier M, Fauchere JL, Perrin J, Grignon B, Oriot D. Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan [letter]. Lancet. 1996;347:828-289.
22. Pluot M, Vital C, Aubertin J, Croix JC, Pire JC, Poisot D. Anthrax meningitis: report of 2 cases with autopsies. Acta Neuropathol (Berl). 1976;36:339-345.
23. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis. 2001;7:933-944.
24. Rangel RA, Gonzalez DA. Bacillus anthracis meningitis. Neurology. 1975;25:525-530.
25. Dixon TC, Meselson M, Guillemin J, Hanna PC. Medical progress: anthrax. N Engl J Med. 1999;341:815-826.
26. Friedlander AM, Pittman PR, Parker GW. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA. 1999;282:2104-2106.